SEC Form 4 · accession 0000912282-26-001157
CalciMedica, Inc. · CALC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
ALAFI CAPITAL CO LLC
10% Owner
Period of report
Aug 19, 2026
Accepted (ET)
Aug 24, 2026 · 5:03 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001534133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 5,112,345 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A WarrantsF1,F2 | $0.8033 | Aug 19, 2026 | A | 3,529,192 | A | — | — | Common Stock | 3,529,192 | 3,529,192 | D |
| Series B WarrantsF3 | $1.00 | Aug 19, 2026 | A | 3,529,192 | A | — | Jun 23, 2031 | Common Stock | 3,529,192 | 3,529,192 | D |
Explanation of responses
- F1The issue date of the Series A Warrants is August 19, 2026.
- F2The expiration of these Series A Warrants is the earlier of (i) 18 months after the closing date of the Private Placement and (ii) 30 days following the Issuer's public announcement of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480.
- F3The issue date of the Series B Warrants is August 19, 2026.